Advisor Committees

Scientific and Regulatory Advisory Committee

 

Melton Affrime, Pharm. D., Senior Vice President, Translational Medicine at WCCT Global

Mark Baumeister, Ph.D.

Martin M. Bednar M.D., Neurosurgeon and Vice President of Takeda Pharmaceuticals, Cambridge, MA, Global Program Lead for Dementia and Parkinson's portfolio, Former Vice Chair of Surgery and Director of Surgical Research at the University of Vermont

Paul J. Camarata, M.D., Chairman of Neurosurgery, University of Kansas, Kansas City, KS

Anthony E. English, Ph.D., Associate Professor Biomedical Engineering, Western New England University, Ph.D. in Medical Engineering and Medical Physics, Massachusetts Institute of Technology
 

David C. Hess, M.D., Professor and Chairman of Neurology, Medical College of Georgia

Philip A. Iredale, Ph.D., Vice President, Head of the Biology Cerevel Therapeutics 

Keith March, M.D., Professor of the Department of Medicine, Indiana University School of Medicine

Stephen McGowan, M.D., Full Professor of Medicine, University of Iowa College of Medicine and Pulmonary Division Director, Iowa Veterans Administrative Hospital, Iowa City, IA

Matthew T. McLeay, M.D., M.S., Midwest Pulmonary Care/MTM Research LLC, Omaha, NE

Maria Alejandra Vazquez-Gragg, M.D., Head of Global Patient Safety, Vice President at Orchard Therapeutics

William Williams, M.D., CEO of BriaCell Therapeutics, New York, NY

Business Development and Finance Advisory Committee

 

William Williams, M.D., CEO of BriaCell Therapeutics, New York, NY

Intersection of Science, Bioethics, Faith and Health Policy Advisory Committee

Philip A. Iredale, Ph.D., Vice President, Head of the Biology Cerevel Therapeutics